Investigation over the last twenty years has implicated neurotrophin signaling in multiple biological processes [11–13], and several lines of evidence demonstrate the role of the brain-derived neurotrophic factor (BDNF) and its cognate receptor, TrkB, in various cancers [14–19]. This evidence concerns the gene NTRK2 and cancer.